Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors

被引:64
|
作者
Gupta, VK
Hariharan, M
Wheatley, TA
Price, JC
机构
[1] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA
[2] Pharmacia Corp, Pharmaceut & Analyt Sci, Skokie, IL USA
[3] FMC Corp, Div Pharmaceut, Princeton, NJ USA
关键词
controlled-release; sustained-release; zero-order; iota-carrageenan; lambda-carrageenan; tablets;
D O I
10.1016/S0939-6411(01)00135-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to investigate the potential of two carrageenans, tau -carrageenan and lambda -carrageenan for the preparation of controlled-release tablets. Tablets were compressed on a Carver press and the effect of formulation factors, moisture, and storage on the release of theophylline was studied. The effect of sodium chloride in the tablet formulation and a change in the ionic strength of the dissolution media was studied on the release of three model drugs. The release rate increased both with an increase in tablet diameter and increase in drug to carrageenan ratio in the tablets. The two lubricants studied had a negligible effect on the rate of drug release at their commonly used concentrations. Moisture content of carrageenans, storage of tablets at 37 degreesC/75% RH for 3 months, and incorporation of 10% sodium chloride in the tablets did not have any significant effect on the release rate. The change in ionic strength of simulated gastric fluid altered the release rate whereas the ionic strength of simulated intestinal fluid did not have a significant effect on the release rate. Carrageenan tablets were relatively insensitive to small changes in formulation parameters and dissolution conditions. (C) 2001 Elsevier Science B.V, All rights reserved.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 50 条
  • [41] Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets
    Reynolds, TD
    Mitchell, SA
    Balwinski, KM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (04) : 457 - 466
  • [42] Formulation of Pregabalin Controlled-Release Tablets: Influence of Some Lipid-Based Matrix Systems on the Release Rate
    Asghar, Muhammad Arif
    Rehman, Ahad Abdul
    Shafiq, Yousra
    Mumtaz, Nazish
    Khan, Kamran
    Asghar, Muhammad Asif
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (11): : 2326 - 2332
  • [43] A GAMMA SCINTIGRAPHIC STUDY OF THE ABSORPTION OF MORPHINE FROM CONTROLLED-RELEASE TABLETS
    OLSSON, B
    WAGNER, ZG
    MANSSON, P
    RAGNARSSON, G
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (02) : 223 - 229
  • [44] BIOAVAILABILITY OF POTASSIUM FROM CONTROLLED-RELEASE TABLETS WITH AND WITHOUT WATER LOADING
    BECHGAARD, H
    SHEPHARD, NW
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) : 143 - 147
  • [45] Effect of Formulation and Process Parameters on Drug Release from Controlled Release Matrix Tablets of Terbulatine Sulphate
    Gulshan, Rabia
    Irfan, Muhammad
    Zahoor, Ameer F.
    Arshad, Muhammad Sohail
    Khan, Nadeem I.
    Hussain, Amjad
    Abbas, Nasir
    Mohsin, Noor-ul-Amin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (02): : 314 - 325
  • [46] CONTROLLED-RELEASE THEOPHYLLINE TABLET FORMULATIONS CONTAINING ACRYLIC RESINS .1. DISSOLUTION PROPERTIES OF TABLETS
    MCGINITY, JW
    CAMERON, CG
    CUFF, GW
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (1-2) : 57 - 68
  • [47] Dissolution stability of multiparticulate controlled release tablets
    Jorgensen, K
    Christensen, FN
    Jacobsen, L
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 153 (01) : 1 - 11
  • [48] Development of the Composition and Technology for Controlled-Release Lornoxicam Tablets
    A. V. Son
    V. A. Vainshtein
    Pharmaceutical Chemistry Journal, 2014, 48 : 51 - 56
  • [49] Fabrication of multiunit controlled-release phenylpropanolamine hydrochloride tablets
    Mitrevej, A
    Sinchaipanid, N
    Natpoolwat, N
    Naratikornrit, N
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (08) : 793 - 796
  • [50] Development of the Composition and Technology for Controlled-Release Lornoxicam Tablets
    Son, A. V.
    Vainshtein, V. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2014, 48 (01) : 51 - 56